We are live on ! Find out more
GI

GAMMA Investing Portfolio holdings

AUM $2.69B
1-Year Est. Return 42.78%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+42.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.17B
AUM Growth
+$164M
Cap. Flow
+$157M
Cap. Flow %
13.37%
Top 10 Hldgs %
25.72%
Holding
3,876
New
301
Increased
2,412
Reduced
769
Closed
99

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$7.19M
2
NVDA icon
NVIDIA
NVDA
+$5.82M
3
MSFT icon
Microsoft
MSFT
+$5.63M
4
AMZN icon
Amazon
AMZN
+$4.37M
5
TSLA icon
Tesla
TSLA
+$3.01M

Sector Composition

Rank Sector Weight
1 Technology 24.89%
2 Financials 12.52%
3 Consumer Discretionary 8.81%
4 Healthcare 7.95%
5 Industrials 7.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WK icon
1826
Workiva
WK
$3.66B
$27K ﹤0.01%
247
+70
+40% +$6.45K
ENR icon
1827
Energizer
ENR
$1.5B
$26.8K ﹤0.01%
768
+356
+86% +$12.3K
CNQ icon
1828
Canadian Natural Resources
CNQ
$97.4B
$26.8K ﹤0.01%
868
-6
-0.7% -$202
DHS icon
1829
WisdomTree US High Dividend Fund
DHS
$1.57B
$26.8K ﹤0.01%
287
+23
+9% +$2.21K
PHO icon
1830
Invesco Water Resources ETF
PHO
$2.09B
$26.8K ﹤0.01%
407
APG icon
1831
APi Group
APG
$18.3B
$26.8K ﹤0.01%
1,116
+211
+23% +$5.02K
CLVT icon
1832
Clarivate
CLVT
$1.21B
$26.7K ﹤0.01%
5,256
+3,245
+161% +$18.7K
OKTA icon
1833
Okta
OKTA
$26.2B
$26.6K ﹤0.01%
338
+57
+20% +$4.42K
LINE
1834
Lineage Inc
LINE
$9.42B
$26.6K ﹤0.01%
454
+448
+7,467% +$30.5K
RGNX icon
1835
Regenxbio
RGNX
$688M
$26.5K ﹤0.01%
3,429
+2,510
+273% +$23.6K
ADTN icon
1836
Adtran
ADTN
$622M
$26.4K ﹤0.01%
3,173
+48
+2% +$354
FBT icon
1837
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.81B
$26.4K ﹤0.01%
159
+53
+50% +$9.06K
VOT icon
1838
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.7B
$26.4K ﹤0.01%
104
-74
-42% -$19K
PRVA icon
1839
Privia Health
PRVA
$2.86B
$26.3K ﹤0.01%
1,345
-356
-21% -$7.05K
CCJ icon
1840
Cameco
CCJ
$42.4B
$26.3K ﹤0.01%
511
+11
+2% +$599
ARCH
1841
DELISTED
Arch Resources, Inc.
ARCH
$26.1K ﹤0.01%
185
+143
+340% +$21.7K
COHU icon
1842
Cohu
COHU
$2.34B
$26.1K ﹤0.01%
977
+326
+50% +$8.53K
MOD icon
1843
Modine Manufacturing
MOD
$10.1B
$26.1K ﹤0.01%
225
+4
+2% +$515
IONS icon
1844
Ionis Pharmaceuticals
IONS
$9.46B
$26.1K ﹤0.01%
746
+82
+12% +$3.06K
ALEX
1845
DELISTED
Alexander & Baldwin
ALEX
$26K ﹤0.01%
1,467
-27
-2% -$509
GRND icon
1846
Grindr
GRND
$2.91B
$25.9K ﹤0.01%
1,454
+326
+29% +$4.75K
LBRT icon
1847
Liberty Energy
LBRT
$3.45B
$25.9K ﹤0.01%
1,304
-1,870
-59% -$34.6K
BILL icon
1848
BILL Holdings
BILL
$4.91B
$25.9K ﹤0.01%
306
+131
+75% +$9.77K
CC icon
1849
Chemours
CC
$2.2B
$25.9K ﹤0.01%
1,532
+765
+100% +$14.9K
RVMD icon
1850
Revolution Medicines
RVMD
$44.4B
$25.9K ﹤0.01%
591
-29
-5% -$1.46K

Similar funds

GAMMA Investing's Q4 2024 Portfolio in Review

As of Q4 2024, GAMMA Investing held 3,876 positions worth $1.17B, up 16% from $1.01B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

GAMMA Investing deployed $157M of net new capital in Q4 2024, opening 301 new positions and adding to 2,412 existing holdings. Its largest new stake was iShares China Large-Cap ETF: 7,320 shares worth $223K.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $1.01M trimmed.

  • GAMMA Investing's largest Q4 2024 buy was iShares China Large-Cap ETF: 7,320 shares worth $223K.
  • GAMMA Investing added most to Apple in Q4 2024, an estimated $7.19M increase.
  • GAMMA Investing's biggest Q4 2024 reduction was Johnson & Johnson, cutting an estimated $1.01M.
  • GAMMA Investing fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $634K.
  • GAMMA Investing's ten largest holdings make up 26% of its $1.17B portfolio in Q4 2024.
  • GAMMA Investing opened 301 new positions and closed 99 in Q4 2024.
  • GAMMA Investing's portfolio value rose 16% quarter-over-quarter to $1.17B.

Based on GAMMA Investing's 13F filing for Q4 2024, filed 3 Jan 2025.